Healthcare - Biotechnology - NASDAQ - US
$ 1.8
-7.22 %
$ 53.4 M
Market Cap
-0.95
P/E
INCOME STATEMENT
0
REVENUE
-58.4 M
OPERATING INCOME
-53.5 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Immuneering Corporation
| Revenue | 0 |
| Cost Of Revenue | 764 K |
| Gross Profit | -764 K |
| Operating Expenses | 58.4 M |
| Operating Income | -58.4 M |
| Other Expenses | -4.94 M |
| Net Income | -53.5 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| REVENUE | |||||
| Revenue | 0 | 0.3 | 2.1 | 2.3 | 1.9 |
| GROSS PROFIT | |||||
| Cost Of Revenue | 0.8 | 0.2 | 1.2 | 1.3 | 1.2 |
| Gross Profit | (0.8) | 0.2 | 0.9 | 1.0 | 0.7 |
| OPERATING INCOME | |||||
| Operating Expenses | 58.4 | 51.9 | 34.8 | 18.1 | 7.0 |
| Selling, General and Administrative Expenses | 16.8 | 15.6 | 8.3 | 3.1 | 2.7 |
| Research and Development Expenses | 41.4 | 36.3 | 26.5 | 15.0 | 4.3 |
| Operating Income | (58.4) | (51.7) | (33.9) | (17.1) | (6.3) |
| PRE-TAX INCOME | |||||
| Interest Income Expense | 0 | 1.0 | 0 | 0 | 0.4 |
| Total Other Income | 4.9 | 1.2 | 42.8 K | 42.7 K | (1.4) |
| Pre-Tax Income | (53.5) | (50.5) | (33.8) | (17.0) | (7.7) |
| NET INCOME | |||||
| Tax Provision | 0 | (1.2) | (0.3) | 84.3 K | 0.4 |
| Net Income | (53.5) | (49.3) | (33.5) | (17.0) | (8.1) |
| EPS | 1.88 | 1.87 | 1.27 | 0.67 | 0.32 |